Market research reports on: The impact of COVID-19 on global markets, economic impact of global coronavirus pandemic, how markets are affected by coronavirus
9773 Reports for Covid-19
Published - Sep 2022 |
Publisher - Partner|
Code - TBR3055A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - PHM264A
Global market for head and neck cancer therapeutics is estimated to increase from $1.7 billion in 2022 to $2.6 billion by 2027, at a CAGR of 8.5% from 2022-27.
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2967A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2968A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2969A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2970A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2971A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2972A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2973A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2974A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2975A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2976A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2977A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2978A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2979A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2980A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2981A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2982A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2983A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2984A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2985A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2986A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2987A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2988A
Published - Sep 2022 |
Publisher - Partner|
Code - TBR2989A
Market research reports on:
9773 Reports for Covid-19
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR3055A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - PHM264A
Global market for head and neck cancer therapeutics is estimated to increase from $1.7 billion in 2022 to $2.6 billion by 2027, at a CAGR of 8.5% from 2022-27.
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2967A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2968A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2969A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2970A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2971A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2972A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2973A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2974A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2975A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2976A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2977A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2978A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2979A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2980A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2981A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2982A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2983A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2984A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2985A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2986A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2987A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2988A
Published - Sep 2022 |
Publisher - BCC Publishing|
Code - TBR2989A
Upcoming reports for this category are not yet released. The titles will be made available closer to the time of launch.
